The Centre for the Commercialization of Antibodies and Biologics (CCAB) Board of Directors is pleased to announce the appointment of Mr. Robert Verhagen as the organization’s new Chief Executive Officer, effective November 1, 2017.

As CCAB’s new CEO, Mr. Verhagen will provide his strategic direction to position CCAB as a leader in the commercialization of academic discoveries in the biologics field and in the advancement of this biotech sector in Canada.

2015 CAAP Company Conavi Medical Inc., a privately-held company developing image guidance technologies for minimally invasive procedures announced that it has entered into an agreement with an affiliate of China Grand Pharmaceutical and Healthcare Holdings Limited (CG Healthcare) to serve as the exclusive distributor of its ForesightTM Intracardiac Echocardiography (ICE) and NovasightTM Hybrid Intravascular Imaging systems in China, Hong Kong, Taiwan and Macau.

Application Deadline January 10, 2018 - Apply Here

The Canadian Technology Accelerator Initiative (CTA) helps high-potential, high-growth Canadian technology SMEs seeking to expand to the U.S through a 5 month program of workshops, events, mentorship and business introductions.

Baylis Medical Company Inc. has launched a hands-on workshop in Europe that will train cardiologists on innovative tools that enable access to the heart from any approach. This includes a growing number of procedures that require physicians to use major veins that feed into the heart from above.

On Tuesday, November 14, Ontario's Minister of Finance, Charles Sousa, delivered the government's Fall Economic Statement.

This year's conference will explore breaking down barriers to innovation within the healthcare ecosystem.

The Trade Commissioner Service in partnership with the province of Ontario and the Chicago Innovation Mentors offers a tailor-made mentoring program focused on life sciences and healthcare innovators working in pharmaceuticals, health IT, and medical devices

in support of research on the impact of Age-Related Macular Degeneration (AMD) by Dr. Shelley Boyd, CEO of Translatum Medicus.

Northern Biologics Inc., a developer of first‐in‐class immuno‐oncology products, announced Philip Vickers, Ph.D., formerly of global head of R&D for Shire, will be joining the company as CEO

Encycle Therapeutics, a Toronto-based drug discovery company, announced a research collaboration with Pfizer to optimize certain nacellins.

This week, VBI Vaccines announced the closing of its public offering which raised approximately US$71.9 Million.

Profound Medical Corp. announced this week that treatments utilizing its TULSA-PRO® technology of Benign Prostatic Hyperplasia (“BPH”) are now being successfully conducted in Germany.

Tieös Pharmaceuticals, a next-generation biotech company focused on cancer metabolic therapies, was selected as a finalist in the 2017 BioInnovation Challenge being held in Halifax, Nova Scotia.

VivaVax is an early-stage life sciences company creating biosafe formulations to protect sensitive medicines from heat fluctuations during transport.

Last week they won the Vinetta Project Finals, which includes a cash prize of $15K, and $25K in legal support from Blakes.

Komodo OpenLabs (CAAP 2015) has won 1st Place at the highly competitive 2017 Interface Health Challenge with their TECLA line.

The prize has a total value of $40K and includes cash, services, and media. Their flagship TECLA product line helps those with physical disabilities effectively use modern day communications devices such as smartphones and tablets.

Mark Elias, Co founder and CEO was featured on CTV's MedicalWatch segment, demonstrating the company's battery-free Steadiglove technology.

Colin Harding, CEO of Iris Technologies authoured a blog featured on the BIST website. Iris Technologies has developed a unique e-reader solution helps people who have suffered from a mild traumatic brain injury (MTBI) or live with chronic migraines regain their ability to comfortably read electronic documents, and assist in their recovery process.

Deadline for Submission October 13, 2017, 5PM EST

Innovation Partnership: Procurement by Co-Design is a unique program that offers healthcare-service providers something rare: the opportunity to participate in the development of innovative solutions before procuring them. In turn, technology and service innovators with scalable business models can gain unprecedented access to end users and validate use cases to remain competitive.

The Ontario Minister of Health and Long-Term Care (the “Minister”) introduced Bill 160:
An Act to amend, repeal and enact various Acts in the interest of strengthening quality and
accountability for patients on September 27, 2017. One of the new enactments is the Health Sector Payment Transparency Act (the “Act”) which will require the reporting of information about financial relationships in the Ontario healthcare system.